We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
The current NRIX market cap is 690.87M. The company's latest EPS is USD -2.9441 and P/E is -4.80.
| Quarter End | Aug 2022 | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 10.79M | 6.78M | 12.69M | 30.68M | 18.47M |
| Operating Income | -46.72M | -48.69M | -42.95M | -26.77M | -40.01M |
| Net Income | -45.71M | -46.72M | -40.73M | -24.28M | -36.98M |
| Year End November 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 31.12M | 17.82M | 29.75M | 38.63M | 76.99M |
| Operating Income | -22.24M | -64.98M | -117.89M | -183.87M | -155.06M |
| Net Income | -21.7M | -43.24M | -117.19M | -180.36M | -143.95M |
| Quarter End | Aug 2022 | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 459.34M | 416.76M | 370.15M | 350.62M | 308.2M |
| Total Liabilities | 116.79M | 113.06M | 96.1M | 90.7M | 74.38M |
| Total Equity | 342.55M | 303.7M | 274.05M | 259.92M | 233.82M |
| Year End November 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 44.05M | 396.34M | 476.77M | 416.76M | 355.6M |
| Total Liabilities | 53.57M | 106.07M | 134.47M | 113.06M | 155.11M |
| Total Equity | -57.71M | 290.27M | 342.3M | 303.7M | 200.49M |
| Quarter End | Aug 2022 | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -121.85M | -159.81M | -48.45M | -66.92M | -108.05M |
| Investing | -27.81M | 27.2M | 16.07M | 59.9M | 82.67M |
| Financing | 117.33M | 117.19M | 1.48M | 1.51M | 3.21M |
| Year End November 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 601k | -80k | -84.37M | -159.81M | -81.37M |
| Investing | 8.5M | -254.4M | -108.25M | 27.2M | 68.3M |
| Financing | 126k | 339.02M | 153.88M | 117.19M | 3.22M |
| Market Cap | 690.87M |
| Price to Earnings Ratio | -4.80 |
| Price to Sales Ratio | 8.97 |
| Price to Cash Ratio | 12.65 |
| Price to Book Ratio | 3.45 |
| Dividend Yield | - |
| Shares Outstanding | 48.89M |
| Average Volume (1 week) | 1.07M |
| Average Volume (1 Month) | 1.42M |
| 52 Week Change | 32.43% |
| 52 Week High | 18.12 |
| 52 Week Low | 4.22 |
| Spread (Intraday) | 3.28 (19.43%) |
| Company Name | Nurix Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.nurixtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
